Sign Out
Augclav should be used with caution in patients with a history of allergic reactions or renal impairment in anamnesis (tablet and 457 mg/5 mL dry syrup only) or hepatic impairment (228 mg/5 mL dry syrup only).
In patients with severe renal impairment, the dosage should be adequately adjusted or the dosing interval prolonged.
1000 mg tablet and dry syrup: The drug should not be used in patients with infectious mononucleosis, cholestatic jaundice or hepatic dysfunction caused by penicillins or amoxicillin/clavulanic acid combinations.
Influence on mental and/or Physical ability: No special warnings.
Use in Pregnancy & Lactation: 625 mg tablet: Safety for use of Augclav 625 in pregnancy has not been established although animal studies revealed no evidence of teratogenicity.
Continue with Google